Company News, Financial News

Pfizer Consumer Healthcare Sale on the Fast Track?

Players are vying for unit that's home to OTC remedies like Advil and Chapstick.

Author Image

By: Christine Esposito

Editor-in-Chief

Pfizer appears to be ramping up its plans to sell its Consumer Healthcarebusiness, home to several high-profile OTC products like Advil and Centrum as well as personal care staples like ChapStick and Anbesol.   According to several reports, the unit could fetch $15 billion or more with firms like GlaxoSmithKline, Reckitt Benckiser among the likely candidates. Also in the mix are Procter & Gamble, J&J and even Nestle, say some analysts.   The company announced earlier this month tha...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters